Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Acute Coronary Syndromes
NCT00754819Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Apr 2008
- Primary completion
- Sep 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in acute coronary syndrome (ACS), sponsored by Hamilton Health Sciences. Started Apr 2008; status: completed.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00754819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754819.